Assessment of the dosage change permitting use in children.
-
Clinical Benefit
Substantial
The actual benefit of this medicinal product is substantial.
Clinical Added Value
no clinical added value
The medicinal product SMOFLIPID has the same actual benefit in the paediatric population as previously recognised by the transparency Committee in adults (IAB V).
Listen
